Activation of hypoxia-induced transcription in normoxia

Experimental Cell Research

Volumn 306, Issue 1, 2005, Pages 180-191

  Hägg, Maria ^a   Wennström, Stefan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Hypoxia; Hypoxia inducible factor; Prolyl hydroxylase; Vascular endothelial growth factor; von Hippel Lindau protein

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; DIMETHYLOXALYLGLYCINE; ENZYME INHIBITOR; GLYCINE; GLYCINE DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLINE; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN A; VON HIPPEL LINDAU PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE ACTIVATION; GENE CONSTRUCT; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HYPOXIA; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPORTER GENE; TRANSCRIPTION INITIATION;

MAMMALIA;

EID: 18844378923     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.01.017     Document Type: Article

References (51)

1. A.L. Harris Hypoxia-a key regulatory factor in tumour growth Nat. Rev., Cancer 2 2002 38 47
2. G.L. Semenza Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology Trends Mol. Med. 7 2001 345 350
3. L.E. Huang, J. Gu, M. Schau, and H.F. Bunn Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway Proc. Natl. Acad. Sci. U. S. A. 95 1998 7987 7992
4. P. Carrero, K. Okamoto, P. Coumailleau, S. O'Brien, H. Tanaka, and L. Poellinger Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha Mol. Cell Biol. 20 2000 402 415
5. M. Ema, K. Hirota, J. Mimura, H. Abe, J. Yodoi, K. Sogawa, L. Poellinger, and Y. Fujii-Kuriyama Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300 Embo J. 18 1999 1905 1914
6. A.L. Kung, S. Wang, J.M. Klco, W.G. Kaelin, and D.M. Livingston Suppression of tumor growth through disruption of hypoxia-inducible transcription Nat. Med. 6 2000 1335 1340
7. P.J. Kallio, K. Okamoto, S. O'Brien, P. Carrero, Y. Makino, H. Tanaka, and L. Poellinger Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha EMBO J. 17 1998 6573 6586
8. A.C. Epstein, J.M. Gleadle, L.A. McNeill, K.S. Hewitson, J. O'Rourke, D.R. Mole, M. Mukherji, E. Metzen, M.I. Wilson, A. Dhanda, Y.M. Tian, N. Masson, D.L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P.H. Maxwell, C.W. Pugh, C.J. Schofield, and P.J. Ratcliffe C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation Cell 107 2001 43 54
9. R.K. Bruick, and S.L. McKnight A conserved family of prolyl-4- hydroxylases that modify HIF Science 294 2001 1337 1340
10. P.H. Maxwell, M.S. Wiesener, G.W. Chang, S.C. Clifford, E.C. Vaux, M.E. Cockman, C.C. Wykoff, C.W. Pugh, E.R. Maher, and P.J. Ratcliffe The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275
11. M.E. Cockman, N. Masson, D.R. Mole, P. Jaakkola, G.W. Chang, S.C. Clifford, E.R. Maher, C.W. Pugh, P.J. Ratcliffe, and P.H. Maxwell Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein J. Biol. Chem. 275 2000 25733 25741
12. T. Kamura, S. Sato, K. Iwai, M. Czyzyk-Krzeska, R.C. Conaway, and J.W. Conaway Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex Proc. Natl. Acad. Sci. U. S. A. 97 2000 10430 10435
13. M. Ohh, C.W. Park, M. Ivan, M.A. Hoffman, T.Y. Kim, L.E. Huang, N. Pavletich, V. Chau, and W.G. Kaelin Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein Nat. Cell Biol. 2 2000 423 427
14. K. Tanimoto, Y. Makino, T. Pereira, and L. Poellinger Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein EMBO J. 19 2000 4298 4309
15. M. Ivan, and W.G. Kaelin Jr. The von Hippel-Lindau tumor suppressor protein Curr. Opin. Genet. Dev. 11 2001 27 34
16. M.H. Glickman, and A. Ciechanover The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction Physiol. Rev. 82 2002 373 428
17. D. Lando, D.J. Peet, J.J. Gorman, D.A. Whelan, M.L. Whitelaw, and R.K. Bruick FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor Genes Dev. 16 2002 1466 1471
18. D. Lando, D.J. Peet, D.A. Whelan, J.J. Gorman, and M.L. Whitelaw Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch Science 295 2002 858 861
19. P.C. Mahon, K. Hirota, and G.L. Semenza FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity Genes Dev. 15 2001 2675 2686
20. K.S. Hewitson, L.A. McNeill, M.V. Riordan, Y.M. Tian, A.N. Bullock, R.W. Welford, J.M. Elkins, N.J. Oldham, S. Bhattacharya, J.M. Gleadle, P.J. Ratcliffe, C.W. Pugh, and C.J. Schofield Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family J. Biol. Chem. 277 2002 26351 26355
21. L.A. McNeill, K.S. Hewitson, J.M. Gleadle, L.E. Horsfall, N.J. Oldham, P.H. Maxwell, C.W. Pugh, P.J. Ratcliffe, and C.J. Schofield The use of dioxygen by HIF prolyl hydroxylase (PHD1) Bioorg. Med. Chem. Lett. 12 2002 1547 1550
22. K.A. Vincent, K.G. Shyu, Y. Luo, M. Magner, R.A. Tio, C. Jiang, M.A. Goldberg, G.Y. Akita, R.J. Gregory, and J.M. Isner Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor Circulation 102 2000 2255 2261
23. D.A. Elson, G. Thurston, L.E. Huang, D.G. Ginzinger, D.M. McDonald, R.S. Johnson, and J.M. Arbeit Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha Genes Dev. 15 2001 2520 2532
24. A. Moren, U. Hellman, Y. Inada, T. Imamura, C.H. Heldin, and A. Moustakas Differential ubiquitination defines the functional status of the tumor suppressor Smad4 J. Biol. Chem. 278 2003 33571 33582
25. P. Jaakkola, D.R. Mole, Y.M. Tian, M.I. Wilson, J. Gielbert, S.J. Gaskell, A. Kriegsheim, H.F. Hebestreit, M. Mukherji, C.J. Schofield, P.H. Maxwell, C.W. Pugh, and P.J. Ratcliffe Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation Science 292 2001 468 472
26. 2 sensing Science 292 2001 464 468
27. F. Yu, S.B. White, Q. Zhao, and F.S. Lee HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation Proc. Natl. Acad. Sci. U. S. A. 98 2001 9630 9635
28. D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
29. D.T. Shima, U. Deutsch, and P.A. D'Amore Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability FEBS Lett. 370 1995 203 208
30. E. Ikeda, M.G. Achen, G. Breier, and W. Risau Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells J. Biol. Chem. 270 1995 19761 19766
31. C.C. Wykoff, N.J. Beasley, P.H. Watson, K.J. Turner, J. Pastorek, A. Sibtain, G.D. Wilson, H. Turley, K.L. Talks, P.H. Maxwell, C.W. Pugh, P.J. Ratcliffe, and A.L. Harris Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res. 60 2000 7075 7083
32. W.G. Kaelin Jr. Molecular basis of the VHL hereditary cancer syndrome Nat. Rev., Cancer 2 2002 673 682
33. C. Blankenship, J.G. Naglich, J.M. Whaley, B. Seizinger, and N. Kley Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity Oncogene 18 1999 1529 1535
34. O. Iliopoulos, M. Ohh, and W.G. Kaelin Jr. pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation Proc. Natl. Acad. Sci. U. S. A. 95 1998 11661 11666
35. A. Schoenfeld, E.J. Davidowitz, and R.D. Burk A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor Proc. Natl. Acad. Sci. U. S. A. 95 1998 8817 8822
36. J.H. Seol, R.M. Feldman, W. Zachariae, A. Shevchenko, C.C. Correll, S. Lyapina, Y. Chi, M. Galova, J. Claypool, S. Sandmeyer, K. Nasmyth, and R.J. Deshaies Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34 Genes Dev. 13 1999 1614 1626
37. T. Kamura, D.M. Koepp, M.N. Conrad, D. Skowyra, R.J. Moreland, O. Iliopoulos, W.S. Lane, W.G. Kaelin Jr., S.J. Elledge, R.C. Conaway, J.W. Harper, and J.W. Conaway Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase Science 284 1999 657 661
38. D. Skowyra, D.M. Koepp, T. Kamura, M.N. Conrad, R.C. Conaway, J.W. Conaway, S.J. Elledge, and J.W. Harper Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1 Science 284 1999 662 665
39. T. Ohta, J.J. Michel, A.J. Schottelius, and Y. Xiong ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity Mol. Cell 3 1999 535 541
40. P. Tan, S.Y. Fuchs, A. Chen, K. Wu, C. Gomez, Z. Ronai, and Z.Q. Pan Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha Mol. Cell 3 1999 527 533
41. A.B. Meriin, V.L. Gabai, J. Yaglom, V.I. Shifrin, and M.Y. Sherman Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis J. Biol. Chem. 273 1998 6373 6379
42. C. Willam, N. Masson, Y.M. Tian, S.A. Mahmood, M.I. Wilson, R. Bicknell, K.U. Eckardt, P.H. Maxwell, P.J. Ratcliffe, and C.W. Pugh Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis Proc. Natl. Acad. Sci. U. S. A. 99 2002 10423 10428
43. J.K. Maranchie, J.R. Vasselli, J. Riss, J.S. Bonifacino, W.M. Linehan, and R.D. Klausner The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma Cancer Cells 1 2002 247 255
44. S. Salceda, and J. Caro Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes J. Biol. Chem. 272 1997 22642 22647
45. C. Warnecke, W. Griethe, A. Weidemann, J.S. Jurgensen, C. Willam, S. Bachmann, Y. Ivashchenko, I. Wagner, U. Frei, M. Wiesener, and K.U. Eckardt Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors FASEB J. 17 2003 1186 1188
46. W.C. Hon, M.I. Wilson, K. Harlos, T.D. Claridge, C.J. Schofield, C.W. Pugh, P.H. Maxwell, P.J. Ratcliffe, D.I. Stuart, and E.Y. Jones Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL Nature 417 2002 975 978
47. J.H. Min, H. Yang, M. Ivan, F. Gertler, W.G. Kaelin Jr., and N.P. Pavletich Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling Science 296 2002 1886 1889
48. J.W. Jeong, M.K. Bae, M.Y. Ahn, S.H. Kim, T.K. Sohn, M.H. Bae, M.A. Yoo, E.J. Song, K.J. Lee, and K.W. Kim Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation Cell 111 2002 709 720
49. J.C. Luo, and M. Shibuya A variant of nuclear localization signal of bipartite-type is required for the nuclear translocation of hypoxia inducible factors (1alpha, 2alpha and 3alpha) Oncogene 20 2001 1435 1444
50. T. Hofer, I. Desbaillets, G. Hopfl, M. Gassmann, and R.H. Wenger Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1alpha activation cascade: implications for HIF-1alpha gene therapy FASEB J. 15 2001 2715 2717
51. I. Groulx, and S. Lee Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein Mol. Cell Biol. 22 2002 5319 5336